April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Mitochondrial Enhancement in RGC and IOP Reduction by MB660 in DBA/2J Mouse
Author Affiliations & Notes
  • H. Kyung
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • K. Park
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • Y. Kim
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • J. Jeoung
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • M. Seo
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • H. Park
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • M. Park
    Mazence incorporation, Suwon, Republic of Korea
  • S. Kim
    Dept of Ophthalmology, Seoul National Univ Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  H. Kyung, None; K. Park, None; Y. Kim, None; J. Jeoung, None; M. Seo, None; H. Park, None; M. Park, Mazence incorporation, P; S. Kim, None.
  • Footnotes
    Support  SNUH GRANT 06-2007-105-0
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2782. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Kyung, K. Park, Y. Kim, J. Jeoung, M. Seo, H. Park, M. Park, S. Kim; Mitochondrial Enhancement in RGC and IOP Reduction by MB660 in DBA/2J Mouse. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2782.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : MB660 is derived from natural compound. This material has neuroprotective effects by enhancing the ratio of NAD+/NADH in the mitochondria. We investigated the neuroprotective effect on retinal ganglion cells(RGC) in DBA/2J mouse.

Methods: : From a preliminary study and dose-dependent study in C57BL/6J mouse, daily experimental MB660 dosage of low(30mg/kg) and high(60mg/kg) dose were determined. Main experiment animals were 7-month-old, male, DBA/2J mice. In the control group, normal diet was applied. In experiment groups, low MB660 diet(low dose group) or high MB660 diet(high dose group) was applied. After 4 weeks later, right eyes were flat-mounted for RGC counting 24hr after DTMR labeling, and left eyes were prepared for axon counting by Bodian staining. Also the number, distribution and shape of the mitochondria were investigated by the transmission EM(TEM) view of the optic nerve in the left eyes. IOP was measured by the rebound tonometer at the first time and 4 weeks later.

Results: : The difference of RGC and axon counts were not statistically significant among three groups. IOP was increased in the control group(21.66 ± 6.49 --> 23.60 ± 7.38 (n=50), p=0.181), but IOP of high dose group was decreased significantly(21.55 ± 5.80 --> 18.88 ± 5.00 (n=40), p=0.017). IOP of low dose group showed the tendency of IOP reduction, however, statistically not significant(21.16 ± 5.97 --> 19.33 ± 6.27 (n=48), p=0.082). TEM view revealed increased number and bigger size of the mitochondria in the experiment groups than control group.

Conclusions: : Four-week-experiment could not confirm neuroprotective effects of MB660 in DBA/2J mice. However, the enhancement of mitochondria and IOP reduction imply future potential of MB660 to be applied in glaucoma treatment.

Keywords: oxidation/oxidative or free radical damage • mitochondria • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×